Medically Supervised Tirzepatide
Weight Loss Programs in Charlotte
and Matthews
At Learn2Lose in Charlotte, North Carolina, we provide medically supervised weight loss programs that may include prescription tirzepatide when clinically appropriate. Our licensed medical providers evaluate each patient individually to determine whether this medication may be an appropriate part of a comprehensive medical weight loss plan.
Tirzepatide is the active ingredient in the FDA-approved medications Zepbound® (approved for chronic weight management) and Mounjaro® (approved for type 2 diabetes). These medications are available by prescription only and must be used under the supervision of a qualified healthcare professional.

At Learn2Lose, tirzepatide is not offered as a standalone product. It is considered only as part of a structured medical weight loss program that includes:
- Comprehensive health history review
- Body composition analysis
- In-person consultation
- Ongoing follow-up visits
- Nutrition and lifestyle guidance

Who May Be a Candidate for Tirzepatide in Charlotte?
Tirzepatide may be considered for adults who meet clinical criteria for medical weight management. Our licensed medical providers assess:
- Body mass index (BMI)
- Body fat percentage
- Metabolic risk factors
- History of diabetes or prediabetes
- Cardiovascular risk
- Prior weight loss attempts
- Current medications
A medical consultation is required to determine eligibility. Not all patients are candidates, and individual results vary.

If prescribed, tirzepatide is used as part of a broader strategy that may include:
- Structured nutritional guidance
- Protein optimization
- Muscle preservation strategies
- Metabolic monitoring
- Regular follow-up appointments
Our goal is sustainable fat reduction with attention to long-term
metabolic health.
Understanding Zepbound®
and Mounjaro®
Zepbound is FDA-approved for chronic weight management in adults who meet specific criteria. Mounjaro is FDA-approved for the treatment of type 2 diabetes and may also support weight reduction in certain patients.
Only a licensed medical provider can determine whether one of these FDA-approved medications may be appropriate. These medications are not cosmetic treatments and are not intended for short-term or appearance-based weight loss.


Safety, Monitoring, and
Ongoing Care
Tirzepatide may cause side effects, including gastrointestinal symptoms. Our medical team provides ongoing monitoring to assess tolerance, dosage adjustments, and overall progress.
Patients with certain medical conditions may not be eligible. A thorough evaluation is required prior to initiating therapy
Tirzepatide Program Pricing, Medical Providers and Safety Information
What it costs
Learn2Lose programs start at $99 per week. The 4-week tirzepatide program is $549. Your $149 initial consultation is credited toward a 4-week program if you choose to start. Learn2Lose is a direct-pay practice, so no insurance is required.
Who supervises your care
Your program is directed by David Croland, DO, board certified in Family Medicine by the National Board of Physicians and Surgeons (NBPAS) and founder of Learn2Lose in 2006. A medical evaluation is required before any medication is prescribed, and your medical provider monitors your progress throughout the program.
Important safety information
Tirzepatide is not right for everyone. It carries a boxed warning about the risk of thyroid C-cell tumors seen in animal studies. Do not use it if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you are pregnant or planning to become pregnant. Common side effects include nausea, vomiting, diarrhea, constipation and stomach discomfort, which are usually most noticeable when starting or increasing a dose. Less common but serious risks include pancreatitis, gallbladder problems, dehydration that can affect the kidneys, and worsening of diabetic eye disease. Tirzepatide may make oral hormonal birth control less effective, so a barrier method is recommended for 4 weeks after starting and after each dose increase. Tell your medical provider about every medication you take and every health condition you have. This information is general and does not replace a medical evaluation.



